Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-market Multi-Center Retrospective-Prospective Study to Assess Long-term Clinical Outcomes of Non-melanoma Skin Cancer Patients Treated With eBx

NCT05257486 is registered in ClinicalTrials.gov with Xoft, Inc. as lead sponsor.

NCT NCT05257486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05257486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-market Multi-Center Retrospective-Prospective Study to Assess Long-term Clinical Outcomes of Non-melanoma Skin Cancer Patients Treated With eBx
Lead sponsor
Xoft, Inc.
Phase
Observational
Overall status
Completed
Start date
March 9, 2022
Completion date
October 13, 2022
Enrollment
183 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non-melanoma skin cancer